You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,117,812


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,117,812
Title:Foamable composition combining a polar solvent and a hydrophobic carrier
Abstract: The present invention relates to a foamable vehicle or cosmetic or pharmaceutical composition, comprising: (1) an organic carrier, at a concentration of 10% to 70% by weight, wherein said organic carrier concurrently comprises: (i) at least one hydrophobic organic carrier, and (ii) at least one polar solvent; (2) at least one surface-active agent; (3) water; and (4) at least one liquefied or compressed gas propellant at a concentration of 3% to 25% by weight of the total composition. The present invention further provides a method of treating, alleviating or preventing a disorder of mammalian subject, comprising administering the above-mentioned compositions to an afflicted target site.
Inventor(s): Tamarkin; Dov (Maccabim, IL), Friedman; Doron (Karmei Yosef, IL), Eini; Meir (Ness Ziona, IL), Besonov; Alex (Rehovot, IL)
Assignee: Foamix Pharmaceuticals Ltd. (Rehovot, IL)
Application Number:11/488,989
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,117,812
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 10,117,812

Introduction to U.S. Patents

The United States Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. A patent is a grant of a property right to the inventor, issued by the USPTO, that allows the inventor to exclude others from making, using, or selling the invention for a specified period, usually 20 years from the date of filing[5].

The Importance of Patent Scope and Claims

Patent scope and claims are crucial elements in defining the boundaries of what is protected by a patent. The scope of a patent determines the breadth of protection it offers, while the claims specify exactly what is protected. Here, we will delve into the specifics of United States Patent 10,117,812, analyzing its scope and claims in detail.

Patent 10,117,812 Overview

To begin, let's identify the key components of United States Patent 10,117,812:

  • Title and Abstract: The title and abstract provide a brief overview of the invention. This is crucial for understanding the general scope of the patent.
  • Background of the Invention: This section explains the context and prior art related to the invention.
  • Summary of the Invention: Here, the inventors summarize the key aspects of their invention.
  • Detailed Description of the Invention: This section provides a detailed explanation of how the invention works and its various embodiments.
  • Claims: The claims are the most critical part of the patent, as they define the legal boundaries of the invention.

Determining Inventorship

Before diving into the claims, it's essential to understand who the inventors are. In U.S. patent law, the true and only inventors must be listed. This involves identifying those who conceived the idea or subject matter of the patent claims. Conception is defined as the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention[2].

Analyzing the Claims

Independent and Dependent Claims

Patent claims can be either independent or dependent. Independent claims stand alone and define the invention without reference to other claims. Dependent claims, on the other hand, refer back to and further limit an independent claim.

  • Independent Claim Length and Count: Research has shown that the length and count of independent claims can be metrics for measuring patent scope. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Claim Language and Scope

The language used in the claims is critical. Broader claims may cover a wider range of embodiments but are more likely to face challenges during the examination process. Narrower claims, while more specific, may offer stronger protection but limit the scope of the invention.

Patent Scope and Its Metrics

Measuring Patent Scope

Patent scope can be measured using various metrics, including:

  • Independent Claim Length: Longer independent claims often indicate a more detailed and specific invention, which can be beneficial for clarity but may limit the scope[3].
  • Independent Claim Count: A higher number of independent claims can suggest a broader invention, but this also increases the complexity and potential for litigation[3].

Impact on Patent Quality and Litigation

The scope of a patent can significantly impact its quality and the likelihood of litigation. Patents with overly broad claims may face more challenges and litigation due to increased licensing and litigation costs. The USPTO has been working to improve patent quality by analyzing trends in patent infringement litigation and linking this information to internal data on the patent examination process[4].

The Examination Process

Role of the USPTO

The USPTO plays a crucial role in ensuring that patents are granted only to inventions that meet the criteria of novelty, non-obviousness, and utility. The examination process involves a thorough review of the patent application, including the claims, to ensure they are clear, concise, and properly scoped.

Common Citation Document (CCD)

During the examination process, tools like the Common Citation Document (CCD) are used to consolidate prior art cited by all participating offices for the family members of a patent application. This helps in visualizing the search results for the same invention produced by several offices on a single page[1].

Patent Infringement and Litigation

Trends in Patent Litigation

The number of patent infringement lawsuits has fluctuated over the years, with significant increases observed around the time of legislative changes, such as the Leahy-Smith America Invents Act (AIA) in 2011. Software-related patents have been a major contributor to the increase in defendants in patent infringement lawsuits[4].

Impact of Nonpracticing Entities (NPEs)

Nonpracticing entities (NPEs), often referred to as "patent trolls," have been a significant factor in patent litigation. They bring about a substantial portion of lawsuits, which can affect the patent landscape by increasing litigation costs and potentially stifling innovation[4].

Practical Considerations for Patent Holders

Correcting Errors in Inventorship

Errors in inventorship can be corrected, but it is crucial to do so without deceptive intent. Incorrect or incomplete identification of inventors can lead to a patent being invalid and unenforceable[2].

Maintaining Patent Validity

To ensure a patent remains enforceable, thorough invention disclosure and accurate identification of inventors are essential. This involves careful documentation and adherence to USPTO guidelines.

Key Takeaways

  • Accurate Inventorship: Correctly identifying the true and only inventors is paramount for the validity of a patent.
  • Claim Language: The scope and clarity of patent claims are critical for defining the legal boundaries of the invention.
  • Patent Scope Metrics: Independent claim length and count can be used to measure patent scope and predict the likelihood of grant and litigation.
  • Examination Process: The USPTO's examination process, including tools like the CCD, ensures that patents meet the necessary criteria.
  • Litigation Trends: Understanding trends in patent litigation, especially the role of NPEs, is vital for navigating the patent landscape.

FAQs

What is the importance of accurate inventorship in a patent application?

Accurate inventorship is crucial because it ensures that the patent is valid and enforceable. Incorrect or incomplete identification of inventors can lead to the patent being invalid and unenforceable[2].

How do independent claim length and count affect patent scope?

Independent claim length and count are metrics used to measure patent scope. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process, while broader claims may face more challenges[3].

What is the role of the Common Citation Document (CCD) in the patent examination process?

The CCD consolidates prior art cited by all participating offices for the family members of a patent application, allowing for a single-page visualization of search results from several offices[1].

How have legislative changes affected patent litigation?

Legislative changes, such as the Leahy-Smith America Invents Act (AIA) in 2011, have influenced the number of patent infringement lawsuits. For example, the AIA led to an increase in the number of lawsuits by causing plaintiffs to break single lawsuits into multiple ones[4].

What are the consequences of deceptive intent in naming inventors?

If there is deceptive intent in naming inventors, the patent is invalid and unenforceable, even if the correct inventorship can be established later[2].

Sources

  1. USPTO - Search for Patents: https://www.uspto.gov/patents/search
  2. Determining Inventorship for US Patent Applications: https://agsci.oregonstate.edu/sites/agsci/files/main/research/vrc_release_inventorship-gattari.pdf
  3. Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Assessing Factors That Affect Patent Infringement Litigation: https://www.gao.gov/products/gao-13-465
  5. U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,117,812

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Leo Pharma As FINACEA azelaic acid AEROSOL, FOAM;TOPICAL 207071-001 Jul 29, 2015 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y TOPICAL TREATMENT OF INFLAMMATORY PAPULES AND PUSTULES OF MILD TO MODERATE ROSACEA ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,117,812

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2003279493 ⤷  Subscribe
Australia 2004261063 ⤷  Subscribe
Australia 2004266502 ⤷  Subscribe
Australia 2004313285 ⤷  Subscribe
Australia 2004321183 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.